Lack of evidence for synaptic high‐affinity γ‐hydroxybutyric acid (GHB) transport in rat brain synaptosomes and 11 Na+‐dependentSLCneurotransmitter transporters-Reference-Cited by-同舟云学术

Lack of evidence for synaptic high‐affinity γ‐hydroxybutyric acid (GHB) transport in rat brain synaptosomes and 11 Na+‐dependentSLCneurotransmitter transporters

Published:2019-01-31 Issue:2 Volume:149 Page:195-210
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Thiesen Louise¹,Frølund Bente¹^ORCID,Wellendorph Petrine¹^ORCID

Affiliation:

1. Department of Drug Design and Pharmacology Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

Funder

Lundbeckfonden

Augustinus Fonden

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.14649

Reference59 articles.

1. α4βδ GABAA receptors are high‐affinity targets for γ‐hydroxybutyric acid (GHB);Absalom N.;Proc. Natl Acad. Sci. USA,2012

2. The therapeutic potential of gamma‐hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data;Addolorato G.;Expert Opin. Investig. Drugs,2009

3. Pharmacological characterization of [3H]ATPCA as a substrate for studying the functional role of the betaine/GABA transporter 1 and the creatine transporter;Al‐Khawaja A.;ACS Chem. Neurosci.,2018

4. Histamine H3 receptor activation inhibits dopamine synthesis but not release or uptake in rat nucleus accumbens;Aquino‐Miranda G.;Neuropharmacology,2016

5. GHB receptor targets in the CNS: focus on high‐affinity binding sites;Bay T.;Biochem. Pharmacol.,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic profiling of Apostichopus japonicus body wall exposed to a typical type of PBDEs: potential health risks and impact on sea cucumber health;Frontiers in Marine Science;2023-09-28

2. The γ-hydroxybutyric acid (GHB) analogue NCS-382 is a substrate for both monocarboxylate transporters subtypes 1 and 4;European Journal of Pharmaceutical Sciences;2020-02